2013•The Chinese Journal of Clinical PharmacologyRequires access

Effects of Cinobufacini injections on the proliferation,apoptosis and expression of topoisomerase II of hepatocarcinoma HepG-2 cells

Xiaonan Cui

Open publisher page 0 citations

Abstract

Objective To investigate the effects of Cinobufacini injections on the expression of topoisomeraseⅡof hepatocarcinoma HepG-2 cells.Methods Experiment were divided into control group and test group(the different Cinobufacini injections group 0.10,0.21,0.42 μg.mL-1).Cell proliferation was assessed by MTT assay.Cell cycles were shown through FCM.The expression of topoisomerase(TOPO Ⅱ) mRNA were analyzed by RT-PCR.Expressions of TOPO Ⅱprotein were analyzed by Western-Blot.Results Cinobufacini injection significantly inhibited HepG-2 cell proliferation(P 0.05) in dose and time-dependent ways,induced tumor cells arrested at the S-phase a dose dependent manner.Down regulated mRNA and protein expressions of TOPOⅡ(P 0.05) in a dose dependent manner.Conclusion Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation,induced tumor cells arrested at the S-phase,regulation of TOPOⅡexpressions might be one of the mechanisms of Cinobufacini injections anti-tumor.

About this research paper

What this paper is about

Objective To investigate the effects of Cinobufacini injections on the expression of topoisomeraseⅡof hepatocarcinoma HepG-2 cells.Methods Experiment were divided into control group and test group(the different Cinobufacini injections group 0.10,0.21,0.42 μg.mL-1).Cell proliferation was assessed by MTT assay.Cell cycles were shown through FCM.The expression of topoisomerase(TOPO Ⅱ) mRNA were analyzed by RT-PCR.Expressions of TOPO Ⅱprotein were analyzed by Western-Blot.Results Cinobufacini injection significantly inhibited HepG-2 cell proliferation(P 0.05) in dose and time-dependent ways,induced tumor cells arrested at the S-phase a dose dependent manner.Down regulated mRNA and protein expressions of TOPOⅡ(P 0.05) in a dose dependent manner.Conclusion Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation,induced tumor cells arrested at the S-phase,regulation of TOPOⅡexpressions might be one of the mechanisms of Cinobufacini injections anti-tumor.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of Cinobufacini injections on the expression of topoisomeraseⅡof hepatocarcinoma HepG-2 cells.Methods Experiment were divided into control group and test group(the different Cinobufacini injections group 0.10,0.21,0.42 μg.mL-1).Cell proliferation was assessed by MTT assay.Cell cycles were shown through FCM.The expression of topoisomerase(TOPO Ⅱ) mRNA were analyzed by RT-PCR.Expressions of TOPO Ⅱprotein were analyzed by Western-Blot.Results Cinobufacini injection significantly inhibited HepG-2 cell proliferation(P 0.05) in dose and time-dependent ways,induced tumor cells arrested at the S-phase a dose dependent manner.Down regulated mRNA and protein expressions of TOPOⅡ(P 0.05) in a dose dependent manner.Conclusion Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation,induced tumor cells arrested at the S-phase,regulation of TOPOⅡexpressions might be one of the mechanisms of Cinobufacini injections anti-tumor.

Key concepts: Apoptosis, Topoisomerase, Western blot, Cell growth, Messenger RNA, Chemistry, Cell, MTT assay

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Cinobufacini injections on the proliferation,apoptosis and expression of topoisomerase II of hepatocarcinoma HepG-2 cells — Research Paper | ScholarLens